Showing results (2371-2380 of 5,486) with videos related to
Sort By:
Pageof 549
Pharmacotherapy|January 13, 2021
Optimizing ceftaroline dosing in critically ill patients undergoing continuous renal replacement therapyShamir Kalaria, Sarah Williford, Dong Guo, et al.Pharmacotherapy|February 15, 2020
Model-Based Analysis of Cannabidiol Dose-Exposure Relationship and BioavailabilitySin Yin Lim, Satish Sharan, Sukyung WooPharmacotherapy|March 8, 2020
Effects of β2-Adrenergic Agonists on Risk of Parkinson's Disease in COPD: A Population-Based StudyWenjia Chen, Mohsen Sadatsafavi, Hamid Tavakoli, et al.Pharmacotherapy|June 15, 2021
Risks and mitigation strategies to prevent etoposide infusion-related reactions in childrenEmma M Tillman, Sarah L Suppes, Nicholas Miles, et al.Pharmacotherapy|January 15, 2014
Comparative effectiveness of linezolid and vancomycin among a national veterans affairs cohort with methicillin-resistant Staphylococcus aureus pneumoniaAisling R Caffrey, Haley J Morrill, Laura A Puzniak, et al.Pharmacotherapy|June 6, 2014
Acute coronary syndrome antiplatelet alternatives in clopidogrel allergyAnastasia M Manchette, Adrienne G Drucker, James L JanuzziPharmacotherapy|June 6, 2014
Novel treatments for familial hypercholesterolemia: pharmacogenetics at workJeffrey A Marbach, Jessica L McKeon, Joyce L Ross, et al.Pharmacotherapy|April 18, 2015
Pharmacotherapy of heart failure with preserved ejection fractionJade E Basaraba, Arden R BarryPharmacotherapy|April 18, 2015
Nationwide evaluation of day-to-day clinical pharmacists' interventions in German hospitalsClaudia Langebrake, Angela Ihbe-Heffinger, Katja Leichenberg, et al.Pharmacotherapy|April 18, 2015
Beneficial effects of a point-of-care bleeding risk calculator on anticoagulant selection in the coronary catheterization laboratoryJocelyn J Kerl, Frank C Spexarth, Rachel Pedersen, et al.Pageof 549